Qianbin Li

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

Archiv der Pharmazie

Future medicinal chemistry

Central South University

Shandong University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central South University

China

Professor :: Department of Medicinal Chemistry

Central South University

China

Associate professor :: Department of Medicinal Chemistry

Virginia Commonwealth University

United States

Postdoc :: Department of Medicinal Chemistry

Education History

Shandong University Sep 01 2003 - Dec 31 2008

China

PHD :: Department of Medicinal Chemistry

Shandong University Sep 01 1999 - Jun 30 2003

China

BSC

Publications

Yuanbo Hu, Congke Zhao, Wenhua Tan, Mengqi Li, Yu Wang, Ruizhe Gao, Zhuo Chen, Zhenming Jin, Liqing Hu, Qianbin Li
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry 67 (15) (2024)
Yuanbo Hu, Congke Zhao, Wenhua Tan, Mengqi Li, Yu Wang, Ruizhe Gao, Zhuo Chen, Zhenming Jin, Liqing Hu, Qianbin Li
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry 67 (15) (2024)
Yuanbo Hu, Congke Zhao, Wenhua Tan, Mengqi Li, Yu Wang, Ruizhe Gao, Zhuo Chen, Zhenming Jin, Liqing Hu, Qianbin Li
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry (2024)
Chao Hao, Meng Cao, Hanyi Ouyang, Zhuo Chen, Gaoyun Hu, Qianbin Li
Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents. Future medicinal chemistry (2023)
Yating Guo, Xiaoding Jiang, Qi Chang, Zhihong Xiao, Zhuo Chen, Dejian Jiang, Gaoyun Hu, Qianbin Li
Novel pyrazolo[3,4-b]pyridine derivatives: Synthesis, structure-activity relationship studies, and regulation of the AMPK/70S6K pathway. Archiv der Pharmazie 355 (7) (2022)
Pan Huang, Xiangyang Le, Fei Huang, Jie Yang, Haofeng Yang, Junlong Ma, Gaoyun Hu, Qianbin Li, Zhuo Chen
Discovery of a Dual Tubulin Polymerization and Cell Division Cycle 20 Homologue Inhibitor via Structural Modification on Apcin. Journal of medicinal chemistry 63 (9) (2020)
Liqing Hu, Lijun Li, Qi Chang, Songsen Fu, Jia Qin, Zhuo Chen, Xiaohui Li, Qinglian Liu, Gaoyun Hu, Qianbin Li
Discovery of Novel Pyrazolo[3,4-b] Pyridine Derivatives with Dual Activities of Vascular Remodeling Inhibition and Vasodilation for the Treatment of Pulmonary Arterial Hypertension. Journal of medicinal chemistry 63 (19) (2020)

Qianbin Li.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qianbin Li